November marks a monumental milestone in the battle against COVID-19. The U.S. Food and Drug Administration (FDA) expanded its emergency use authorization (EUA) for the Pfizer-BioNTech vaccine to children ages 5 to 11.This means, all children over the age of 5 are eligible to receive a COVID-19 vaccination. Pfizer is
© 2022. All Rights Reserved by Mechtech Designers & Engineers Pvt. Ltd. | Designed & Developed by BNTECHNO.
